In the cross‐sectional analyses, higher plasma afamin concentrations were associated with more pronounced increases in the NAFLD LFS in men and in people with prediabetes or diabetes (all pinteraction < .001). The gene discussed is AFM; the disease is metabolic dysfunction-associated steatotic liver disease.